Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03934840
Title Phase 2 of Carbo, Taxel and Abi in Metastatic Castration Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Masonic Cancer Center, University of Minnesota
Indications

prostate cancer

Therapies

Abiraterone + Cabazitaxel + Carboplatin + Prednisone

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.